Bile acid levels are increased in the liver of patients with steatohepatitis

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 6, 2008, Pages 519-525

  Aranha, Márcia M ^a   Cortez Pinto, Helena ^b,c,d   Costa, Adília ^c   Da Silva, Isabel B Moreira ^a   Camilo, Maria E ^b   De Moura, Miguel Carneiro ^c,d   Rodrigues, Cecília M P ^a,e  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c HOSPITAL DE SANTA MARIA   (Portugal)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^e UNIVERSITY OF LISBON   (Portugal)

Author keywords

Alcoholic and nonalcoholic steatohepatitis; Bile acids; Fibrosis; Inflammation; Liver injury

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID;

ADULT; ALCOHOLIC FATTY LIVER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GAS LIQUID CHROMATOGRAPHY; HEPATITIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; STEATOSIS;

ADULT; BILE ACIDS AND SALTS; BIOPSY; CHENODEOXYCHOLIC ACID; CHOLIC ACID; CHROMATOGRAPHY, GAS; DEOXYCHOLIC ACID; DISEASE PROGRESSION; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 43449094989     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f4710a     Document Type: Article

References (37)

1. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003; 72:137-174.
2. Schmucker DL, Ohta M, Kanai S, Sato Y, Kitani K. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990; 12:1216-1221.
3. Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak WM, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology 1991; 100:203-211.
4. Quist RG, Ton-Nu HT, Lillienau J, Hofmann AF, Barrett KE. Activation of mast cells by bile acids. Gastroenterology 1991; 101:446-456.
5. Jaeschke H, Gujral JS, Bajt ML. Apoptosis and necrosis in liver disease. Liver Int 2004; 24:85-89.
6. Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994; 94:2183-2192.
7. Spivey JR, Bronk SF, Gores GJ. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest 1993; 92:17-24.
8. Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998; 101:2790-2799.
9. Botla R, Spivey JR, Aguilar H, Bronk SF, Gores GJ. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther 1995; 272:930-938.
10. Fischer S, Beuers U, Spengler U, Zwiebel FM, Koebe HG. Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin Chim Acta 1996; 251:173-186.
11. Greim H, Trulzsch D, Czygan P, Rudick J, Hutterer F, Schaffner F, et al. Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction. Gastroenterology 1972; 63:846-850.
12. Setchell KD, Rodrigues CM, Clerici C, Solinas A, Morelli A, Gartung C, et al. Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology 1997; 112:226-235.
13. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55:434-438.
14. Pinto HC, Baptista A, Camilo ME, Valente A, Saragoca A, de Moura MC. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996; 41:172-179.
15. Setchell KD, Lawson AM, Tanida N, Sjovall J. General methods for the analysis of metabolic profiles of bile acids and related compounds in feces. J Lipid Res 1983; 24:1085-1100.
16. Hirano T, Kaplowitz N, Stukamoto H, Kamimura S, Fernandez-Checa J. Hepatic mitochondrial gluatahtione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 1992; 16:1423-1427.
17. Alme B, Bremmelgaard A, Sjovall J, Thomassen P. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatography-mass spectrometry. J Lipid Res 1977; 18:339-362.
18. Blau K, King G. Handbook of derivates for chromatography. London: Heyden; 1978.
19. Axelson M, Sjovall J. Separation and computerized gas chromatography-mass spectrometry of unconjugated neutral steroids in plasma. J Steroid Biochem 1974; 5:733-738.
20. Akashi Y, Miyazaki H, Nakayama F. Correlation of bile acid composition between liver tissue and bile. Clin Chim Acta 1983; 133:125-132.
21. Honda A, Yoshida T, Tanaka N, Matsuzaki Y, He B, Shoda J, et al. Increased bile acid concentration in liver tissue with cholesterol gallstone disease. J Gastroenterol 1995; 30:61-66.
22. Yanagisawa J, Itoh M, Ishibashi M, Miyazaki H, Nakayama F. Microanalysis of bile acid in human liver tissue by selected ion monitoring. Anal Biochem 1980; 104:75-86.
23. Guicciardi ME, Gores GJ. Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease. Dig Liver Dis 2002; 34:387-392.
24. Rodrigues CM, Steer CJ. Mitochondrial membrane perturbations in cholestasis. J Hepatol 2000; 32:135-141.
25. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103:137-145.
26. Higuchi H, Yoon JH, Grambihler A, Werneburg N, Bronk SF, Gores GJ. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis. J Biol Chem 2003; 278:454-461.
27. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998; 4:165-178.
28. Rodrigues CM, Ma X, Linehan-Stieers C, Fan G, Kren BT, Steer CJ. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ 1999; 6:842-854.
29. Kobak GE, Dahl R, Devereaux MW, Gumpricht E, Traber M, Doctor RB, et al. Increased susceptibility of fat-laden Zucker-rat hepatocytes to bile acid-induced oncotic necrosis: an in vitro model of steatocholestasis. J Lab Clin Med 2005; 145:247-262.
30. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002; 36:525-531.
31. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003; 112:152-159.
32. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, et al. Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125:437-443.
33. Ribeiro PS, Cortez-Pinto H, Sola S, Castro RE, Ramalho RM, Baptista A, et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004; 99:1708-1717.
34. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004; 40:185-194.
35. Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 2006; 281:12093-12101.
36. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J Hepatol 2001; 35:134-146.
37. Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 2004; 39:770-778.